For: | Tang NN, Zhu H, Zhang HJ, Zhang WF, Jin HL, Wang L, Wang P, He GJ, Hao B, Shi RH. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. World J Gastroenterol 2014; 20(47): 17894-17904 [PMID: 25548487 DOI: 10.3748/wjg.v20.i47.17894] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i47/17894.htm |
Number | Citing Articles |
1 |
Muhammad Azhar Nisar, Qin Zheng, Muhammad Zubair Saleem, Bulbul Ahmmed, Muhammad Noman Ramzan, Syed Riaz Ud Din, Naeem Tahir, Shuai Liu, Qiu Yan. IL-1β Promotes Vasculogenic Mimicry of Breast Cancer Cells Through p38/MAPK and PI3K/Akt Signaling Pathways. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.618839
|
2 |
Ran Fu, Wenwen Du, Zongli Ding, Yi Wang, Yue Li, Jianjie Zhu, Yuanyuan Zeng, Yulong Zheng, Zeyi Liu, Jian-an Huang. HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment. Cell Death & Disease 2021; 12(4) doi: 10.1038/s41419-021-03682-z
|
3 |
Elif Isil Yücel, Mehmet Sahin. Fenretinide reduces angiogenesis by downregulating CDH5, FOXM1 and eNOS genes and suppressing microRNA-10b. Molecular Biology Reports 2020; 47(3): 1649 doi: 10.1007/s11033-020-05252-6
|
4 |
Shuixian Li, Wen Meng, Ziwei Guan, Yuanling Guo, Xiuzhen Han. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment. Biomedicine & Pharmacotherapy 2016; 80: 127 doi: 10.1016/j.biopha.2016.03.010
|
5 |
Yanzi Qin, Wenjun Zhao, Zhaogeng Cai, Qi Wang, Jin Gao, Hongfei Ci, Zhenzhong Feng, Li Ma, Muhammad Muddassir Ali. The Biomarker Like the Correlation between Vasculogenic Mimicry, Vascular Endothelial Cadherin, Sex-DeterminingRegion on Y-Box Transcription Factor 17, and Cyclin D1 in Oesophageal Squamous Cell Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/8915503
|
6 |
Wenjing Yong, Yu Jian, Qi Wang, Kuilin Fei, Ping Li. AC092100.1 promotes angiogenesis in pre-eclampsia through YTHDC2/VEGFA signaling. Functional & Integrative Genomics 2024; 24(5) doi: 10.1007/s10142-024-01428-6
|
7 |
C. Sanhueza, S. Wehinger, J. Castillo Bennett, M. Valenzuela, G. I. Owen, A. F. G. Quest. The twisted survivin connection to angiogenesis. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0467-1
|
8 |
Ba Da Yun, Seung Wan Son, Soo Young Choi, Hyo Jeong Kuh, Tae-Jin Oh, Jong Kook Park. Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha. International Journal of Molecular Sciences 2021; 22(18): 9819 doi: 10.3390/ijms22189819
|
9 |
Jan Dreute, Maximilian Pfisterer, M. Lienhard Schmitz. A reductionist perspective on HIF-1α's role in cell proliferation under non-hypoxic conditions. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2024; 1871(3): 119683 doi: 10.1016/j.bbamcr.2024.119683
|
10 |
YuLing Xu, LingMeng Fu, Da Pan, Jie Wei, Hui Xia, ShaoKang Wang, GuiJu Sun. Folic Acid Inhibited Vasculogenic Mimicry in Esophageal Cancer Cell Line Eca-109, the One Target Was EphA2. Nutrition and Cancer 2022; 74(6): 2235 doi: 10.1080/01635581.2021.1988992
|
11 |
Fatima M. Shakova, Yuliya I. Kirova, Denis N. Silachev, Galina A. Romanova, Sergey G. Morozov. Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis. Brain Sciences 2021; 11(3): 325 doi: 10.3390/brainsci11030325
|
12 |
Yuqin Ding, Kaijing Ding, Wangang Gong, Haibin Wei, Wenju Mo, Xiaowen Ding. WITHDRAWN: Long non-coding RNA LUCAT1 up-regulates the expression of HIF-1α and promotes the proliferation and metastasis of breast cancer cells via sponging miR-199a-5p. Biomedical Journal 2020; doi: 10.1016/j.bj.2020.07.010
|
13 |
Lan Yu, Bo Zhu, Shiwu Wu, Lei Zhou, Wenqing Song, Xiaomeng Gong, Danna Wang. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma. Diagnostic Pathology 2017; 12(1) doi: 10.1186/s13000-017-0612-9
|
14 |
Hongfei Ci, Zhouyi Xu, Jing Xu, Yichao Wang, Shiwu Wu. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry. Medicine 2018; 97(40): e12293 doi: 10.1097/MD.0000000000012293
|
15 |
Yingjun Zhu, Xihong Liu, Peiyuan Zhao, Hui Zhao, Wei Gao, Lei Wang. Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00025
|
16 |
Jingxin Zhang, Guodong Deng, Lili Qiao, Hui Luo, Qiqi Liu, Ning Liang, Jian Xie, Jiandong Zhang. Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.7959
|
17 |
Hao‐fan Wang, Sha‐sha Wang, Min Zheng, Lu‐ling Dai, Ke Wang, Xiao‐lei Gao, Ming‐xin Cao, Xiang‐hua Yu, Xin Pang, Mei Zhang, Jing‐biao Wu, Jia‐shun Wu, Xiao Yang, Ya‐jie Tang, Yu Chen, Ya‐ling Tang, Xin‐hua Liang. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma. Cell Proliferation 2019; 52(3) doi: 10.1111/cpr.12600
|
18 |
Yu Miao, Xiaofei Wang, Yafang Lai, Wan Lin, Ying Huang, Hua Yin, Ruirui Hou, Feixiong Zhang. Mitochondrial calcium uniporter promotes cell proliferation and migration in esophageal cancer. Oncology Letters 2021; 22(3) doi: 10.3892/ol.2021.12947
|
19 |
Bo Zhu, Lei Zhou, Lan Yu, Shiwu Wu, Wenqing Song, Xiaomeng Gong, Danna Wang. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma. BMC Surgery 2017; 17(1) doi: 10.1186/s12893-017-0246-6
|
20 |
Jian Yang, Xu Zhang, Yi Zhang, Dongming Zhu, Lifeng Zhang, Ye Li, Yanbo Zhu, Dechun Li, Jian Zhou. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0298-y
|
21 |
Mónica Fernández-Cortés, Daniel Delgado-Bellido, F. Javier Oliver. Vasculogenic Mimicry: Become an Endothelial Cell “But Not So Much”. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00803
|
22 |
Ross King, Conall Hayes, Claire L Donohoe, Margaret R Dunne, Maria Davern, Noel E Donlon. Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers. World Journal of Gastrointestinal Oncology 2021; 13(5): 312-331 doi: 10.4251/wjgo.v13.i5.312
|
23 |
Daniel Delgado-Bellido, Santiago Serrano-Saenz, Mónica Fernández-Cortés, F. Javier Oliver. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0631-x
|
24 |
Elena Andreucci, Silvia Peppicelli, Jessica Ruzzolini, Francesca Bianchini, Lido Calorini. Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry. Cancer and Metastasis Reviews 2022; 41(4): 935 doi: 10.1007/s10555-022-10067-x
|
25 |
Stephen L. Wechman, Luni Emdad, Devanand Sarkar, Swadesh K. Das, Paul B. Fisher. . Advances in Cancer Research 2020; 148: 27 doi: 10.1016/bs.acr.2020.06.001
|
26 |
Maria Davern, Noel E. Donlon, Robert Power, Conall Hayes, Ross King, Margaret R. Dunne, John V. Reynolds. The tumour immune microenvironment in oesophageal cancer. British Journal of Cancer 2021; 125(4): 479 doi: 10.1038/s41416-021-01331-y
|
27 |
Gabriela Morales-Guadarrama, Rocío García-Becerra, Edgar Armando Méndez-Pérez, Janice García-Quiroz, Euclides Avila, Lorenza Díaz. Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers. Cells 2021; 10(7): 1758 doi: 10.3390/cells10071758
|
28 |
Xianjie Jiang, Jie Wang, Xiangying Deng, Fang Xiong, Shanshan Zhang, Zhaojian Gong, Xiayu Li, Ke Cao, Hao Deng, Yi He, Qianjin Liao, Bo Xiang, Ming Zhou, Can Guo, Zhaoyang Zeng, Guiyuan Li, Xiaoling Li, Wei Xiong. The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01709-5
|
29 |
Qiu Du, Yingda Lin, Changping Ding, Ling Wu, Yuan Xu, Qingling Feng. Pharmacological Activity of Matrine in Inhibiting Colon Cancer Cells VM Formation, Proliferation, and Invasion by Downregulating Claudin-9 Mediated EMT Process and MAPK Signaling Pathway. Drug Design, Development and Therapy 2023; : 2787 doi: 10.2147/DDDT.S417077
|
30 |
Nan Zhao, Huizhi Sun, Baocun Sun, Dongwang Zhu, Xiulan Zhao, Yong Wang, Qiang Gu, Xueyi Dong, Fang Liu, Yanhui Zhang, Xiao Li. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Scientific Reports 2016; 6(1) doi: 10.1038/srep23091
|
31 |
Nazila Fathi Maroufi, Sina Taefehshokr, Mohammad-Reza Rashidi, Nima Taefehshokr, Mahdieh Khoshakhlagh, Alireza Isazadeh, Narmin Mokarizadeh, Behzad Baradaran, Mohammad Nouri. Vascular mimicry: changing the therapeutic paradigms in cancer. Molecular Biology Reports 2020; 47(6): 4749 doi: 10.1007/s11033-020-05515-2
|
32 |
Yuqi Shi, Wenjuan Li, Qianhao Jia, Jiatao Wu, Shoufan Wu, Shiwu Wu. Inhibition of PD-L1 expression in non-small cell lung cancer may reduce vasculogenic mimicry formation by inhibiting the epithelial mesenchymal transformation process. Experimental Cell Research 2024; 437(1): 113996 doi: 10.1016/j.yexcr.2024.113996
|
33 |
Jiao Tang, Jianguo Wang, Lin Fan, Xiaoxuan Li, Na Liu, Wanxian Luo, Jihui Wang, Yifeng Wang, Ying Wang. cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer. Oncotarget 2016; 7(17): 24050 doi: 10.18632/oncotarget.8079
|
34 |
Haitao Hu, Ting Ma, Nanqi Liu, Hong Hong, Lujiao Yu, Dantong Lyu, Xin Meng, Biao Wang, Xuefeng Jiang. Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: Tumor immune microenvironments, and drugs. International Immunopharmacology 2022; 111: 109116 doi: 10.1016/j.intimp.2022.109116
|
35 |
Stuart C. Williamson, Robert L. Metcalf, Francesca Trapani, Sumitra Mohan, Jenny Antonello, Benjamin Abbott, Hui Sun Leong, Christopher P. E. Chester, Nicole Simms, Radoslaw Polanski, Daisuke Nonaka, Lynsey Priest, Alberto Fusi, Fredrika Carlsson, Anders Carlsson, Mary J. C. Hendrix, Richard E. B. Seftor, Elisabeth A. Seftor, Dominic G. Rothwell, Andrew Hughes, James Hicks, Crispin Miller, Peter Kuhn, Ged Brady, Kathryn L. Simpson, Fiona H. Blackhall, Caroline Dive. Vasculogenic mimicry in small cell lung cancer. Nature Communications 2016; 7(1) doi: 10.1038/ncomms13322
|
36 |
Yue-Jie Li, Xin Qing, Qing-Xu Tao, Li Xiang, Li Gong, Tie-Jun Zhou. Vasculogenic Mimicry Formation Is Associated with Erythropoietin Expression but Not with Erythropoietin Receptor Expression in Cervical Squamous Cell Carcinoma. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1934195
|
37 |
Marco A. Andonegui-Elguera, Yair Alfaro-Mora, Rodrigo Cáceres-Gutiérrez, Claudia Haydee Sarai Caro-Sánchez, Luis A. Herrera, José Díaz-Chávez. An Overview of Vasculogenic Mimicry in Breast Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00220
|
38 |
Hengmin Han, Seon-Ok Lee, Yinzhu Xu, Jung-Eun Kim, Hyo-Jeong Lee. SPHK/HIF-1α Signaling Pathway Has a Critical Role in Chrysin-Induced Anticancer Activity in Hypoxia-Induced PC-3 Cells. Cells 2022; 11(18): 2787 doi: 10.3390/cells11182787
|
39 |
Parviz Mammadzada, Pablo M. Corredoira, Helder André. The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective. Cellular and Molecular Life Sciences 2020; 77(5): 819 doi: 10.1007/s00018-019-03422-9
|
40 |
Bo-Chang Wu, Angela Ting-Wei Hsu, Sanaz Nourmohammadi Abadchi, Christopher R. Johnson, Sameer Bengali, Frank Lay, Kelsey Melinosky, Chunbo Shao, Kai-Hua Chang, Louis J. Born, John Abraham, David Evans, Jinny S. Ha, John W. Harmon. Potential Role of Silencing Ribonucleic Acid for Esophageal Cancer Treatment. Journal of Surgical Research 2022; 278: 433 doi: 10.1016/j.jss.2022.04.029
|
41 |
Olga N. Hernández de la Cruz, José Sullivan López-González, Raúl García-Vázquez, Yarely M. Salinas-Vera, Marcos A. Muñiz-Lino, Dolores Aguilar-Cazares, César López-Camarillo, Ángeles Carlos-Reyes. Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors. Frontiers in Oncology 2020; 9 doi: 10.3389/fonc.2019.01419
|
42 |
Ana Cavaco, Maryam Rezaei, Stephan Niland, Johannes A. Eble. Collateral Damage Intended—Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy. International Journal of Molecular Sciences 2017; 18(11): 2355 doi: 10.3390/ijms18112355
|